Shandong Huangshengtang Pharmaceutical Co., Ltd. is a large-scale enterprise integrating new drug R&D, transdermal patch manufacturing, and sales. For 14 years, the company has been dedicated to the production of topical patch products. It is a major patch manufacturer in Shandong Province and a leading pharmaceutical production base nationwide, renowned among patch manufacturers across China. The company’s flagship products cater to gynecology, pediatrics, and rheumatic and musculoskeletal diseases, with an annual production capacity exceeding 500 million patches. Its products are marketed in more than 30 provinces, autonomous regions, and municipalities across China and are exported to over 70 countries and regions including the United States, the European Union, Japan, and India, with import and export turnover reaching 300 million U.S. dollars. The group has successively received numerous honors, including “High-Tech Enterprise” from Heze City, “AAA-Quality and Integrity Brand Enterprise” of Shandong Province, “AAA-Trustworthy Brand Enterprise” recognized by consumers nationwide, and “National Model Integrity Unit.” Adhering to the business philosophy of “Professionalism, Dedication, and Focus,” the company plays an increasingly important role in safeguarding public health and promoting industry development. Currently, the company boasts its own independent R&D platform, with 38 researchers holding master’s degrees or higher and 9 holding doctoral degrees or higher. Moreover, it has established extensive collaborative partnerships with more than 30 universities, colleges, and research institutions, including the Faculty of Medicine at the National University of Singapore, the School of Medicine at Nanjing University, China Pharmaceutical University, China Medical University, and the School of Medicine at Southeast University, consistently staying at the forefront of scientific and technological innovation. The company operates nine national-level laboratories, three of which have been certified by the International Conference on Medical Device Laboratories in San Jose, USA. These laboratories adhere to the internationally recognized Brussels medical laboratory standards and all employ space-grade sterile operating procedures. All raw materials used in the laboratories are imported from French pharmaceutical laboratories, while the required raw materials are exclusively supplied by Tongrentang of China. With nearly stringent standards, the company has created laboratories that are virtually flawless. It is here that China’s high-end medical patches are born.Companies
